(Q46508141)

22 December 2017

title

Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study Group (English)

1 reference

22 December 2017

author name string

Chihiro Shimazaki

1

1 reference

22 December 2017

Hiroshi Fujii

2

1 reference

22 December 2017

Takashi Yoshida

3

1 reference

22 December 2017

Takaaki Chou

4

1 reference

22 December 2017

Miki Nishimura

5

1 reference

22 December 2017

Hideki Asaoku

6

1 reference

22 December 2017

Shuichi Miyawaki

7

1 reference

22 December 2017

Akihiro Ishii

8

1 reference

22 December 2017

Tadao Ishida

9

1 reference

22 December 2017

Masafumi Taniwaki

10

1 reference

22 December 2017

Shinsuke Iida

11

1 reference

22 December 2017

Toshiyuki Takagi

12

1 reference

22 December 2017

Kiyoshi Takatsuki

13

1 reference

22 December 2017

Japan Myeloma Study Group

14

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

International Journal of Hematology

published in

1 reference

22 December 2017

volume

81

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

342-348

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1532/ijh97.04174

exact match

0 references

cites work

Graft-versus-myeloma effect in two cases

1 reference

12 December 2020

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation

1 reference

12 December 2020

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

12 December 2020

The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma

1 reference

12 December 2020

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

1 reference

12 December 2020

Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning

1 reference

12 December 2020

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.

1 reference

12 December 2020

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

1 reference

12 December 2020

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

1 reference

12 December 2020

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

1 reference

12 December 2020

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

12 December 2020

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma

1 reference

12 December 2020

Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome

1 reference

12 December 2020

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.

1 reference

12 December 2020

1 reference

12 December 2020

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

12 December 2020

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

12 December 2020

Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homoge

1 reference

12 December 2020

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

1 reference

12 December 2020

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

1 reference

12 December 2020

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

12 December 2020

Follow‐up of patients with progressive multiple myeloma undergoing allografts after reduced‐intensity conditioning

1 reference

12 December 2020

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

12 December 2020

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

12 December 2020

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

1 reference

12 December 2020

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.04174

1 reference

22 December 2017

Dimensions Publication ID

1006465717

0 references

1 reference

22 December 2017